VOROLANIB

Clinical trials for VOROLANIB explained in plain language.

Never miss a new study

Get alerted when new VOROLANIB trials appear

Sign up with your email to follow new studies for VOROLANIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to save kidneys in tough cancer cases

Disease control Recruiting now

This study is testing if a combination of two drugs, pucotenlimab and vorolanib, can shrink kidney tumors before surgery. The goal is to make it possible for surgeons to remove the cancer while saving the healthy part of the kidney in patients where this is normally very difficul…

Matched conditions: VOROLANIB

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

VOROLANIB

Get alerted when new VOROLANIB trials appear

New drug combo aims to save kidneys in tough cancer cases